NOTCH1 activation is also associated with aggressive CLL clinical behavior and decreased time-to-first treatment [22,23], but this association does not correlate with NOTCH1 and IGHV mutational status [22]. This evidence concerns the gene NOTCH1 and B-cell chronic lymphocytic leukemia.